Growth Metrics

Health Catalyst (HCAT) Cash from Investing Activities (2018 - 2025)

Health Catalyst (HCAT) has disclosed Cash from Investing Activities for 8 consecutive years, with -$9.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Investing Activities fell 222.33% year-over-year to -$9.4 million, compared with a TTM value of -$77.6 million through Sep 2025, down 164.76%, and an annual FY2024 reading of -$22.9 million, down 212.86% over the prior year.
  • Cash from Investing Activities was -$9.4 million for Q3 2025 at Health Catalyst, up from -$52.2 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $96.8 million in Q1 2025 and bottomed at -$172.8 million in Q3 2021.
  • Average Cash from Investing Activities over 5 years is -$7.7 million, with a median of -$1.8 million recorded in 2024.
  • The sharpest move saw Cash from Investing Activities crashed 4245.93% in 2021, then soared 1267.69% in 2023.
  • Year by year, Cash from Investing Activities stood at -$76.7 million in 2021, then surged by 108.16% to $6.3 million in 2022, then soared by 378.21% to $29.9 million in 2023, then plummeted by 476.87% to -$112.7 million in 2024, then skyrocketed by 91.7% to -$9.4 million in 2025.
  • Business Quant data shows Cash from Investing Activities for HCAT at -$9.4 million in Q3 2025, -$52.2 million in Q2 2025, and $96.8 million in Q1 2025.